Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy
Jiang‐Jiang Qin(Zhejiang Chinese Medical University), Ruiwen Zhang(Institute of Pharmacology)
Cited by 29
Related Papers
The MDM2-p53 pathway revisited
|Journal of Biomedical Research|2013|410
<i>In vitro</i> and <i>In vivo</i> Anticancer Activity of Novel Synthetic Makaluvamine Analogues
|Clinical Cancer Research|2009|65
Recent Advances in Validating MDM2 as a Cancer Target
|Anti-Cancer Agents in Medicinal Chemistry|2009|48
Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis
|Molecular Cancer|2022|48
Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy
|Journal of Biomedical Research|2016|23